Quidel shareholders approved the merger agreement with Ortho Clinical Diagnostics Holdings. Ortho shareholders will receive $7.14 and 0.1055 shares of Quidel stock for each of their securities and will own 38% of the combined company. The merger is scheduled to close on May 27.